ZD6474 (vandetanib) 300mg

DRUG3 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

AdenocarcinomaCarcinomaColorectalLung CancerMetastaticNon Small Cell Lung CarcinomaNon-Small Cell Lung

Phase 1

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

CompletedNCT00507091

Genzyme, a Sanofi CompanyAdenocarcinoma, Colorectal, Metastatic

Start: 2005-08-31End: 2008-06-30Updated: 2016-08-25

ZD6474(Vandetanib) + Alimta Combo Study

CompletedNCT00506051

Genzyme, a Sanofi CompanyCarcinoma, Lung Cancer, Non-Small Cell Lung

Start: 2005-07-31End: 2011-10-31Updated: 2016-08-25

Phase 2

ZD6474 Phase IIa Dose Finding Multicentre Study

CompletedNCT00252746

Genzyme, a Sanofi CompanyNon Small Cell Lung Carcinoma

Start: 2004-12-31End: 2007-01-31Updated: 2016-08-25